Visa-versa! Breaking Instead of Pushing the Pedals-B
1 other identifier
interventional
17
1 country
1
Brief Summary
Eccentric muscle work is defined as lengthening of a muscle while applying force. It was shown that with eccentric work, muscles are able to perform four times as much power compared to usual concentric work, which results in huge training gain with a highly decreased oxygen demand and thus lower cardiovascular load. Pulmonary hypertension (PH) is a chronic condition associated with significant reduced exercise capacity and increased morbidity and mortality, resulting in reduced quality of life. Physical training has been shown to be beneficial in PH, even in severely limited patients. However, due to cardiopulmonary constraints in PH, training intensities may be very low, so that many patients are physically almost unable to perform exercise on a high enough level to maintain muscle mass. A low body muscle not only feeds the vicious cycle of decreasing exercise capacity, but also has many deleterious metabolic and immunological consequences which further increase disability and decrease quality of life in PH. Thus, eccentric training, which allows to gain muscle mass with a low stress to the cardiopulmonary unit may to be highly beneficial for patients with PH and allied cardiopulmonary disease, such as chronic obstructive pulmonary disease (COPD) and heart failure. Therefore, the aim of the study is to compare differences in oxygen uptake (peak VO2 \[l/min\]) and other physiological measures during similar cardiopulmonary exercise test protocols of eccentric- vs. concentric cycling in PH- patients and comparators with or without other cardiopulmonary diseases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable chronic-obstructive-pulmonary-disease
Started Nov 2023
Shorter than P25 for not_applicable chronic-obstructive-pulmonary-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 6, 2021
CompletedFirst Posted
Study publicly available on registry
January 11, 2022
CompletedStudy Start
First participant enrolled
November 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2024
CompletedJanuary 23, 2025
January 1, 2025
7 months
December 6, 2021
January 20, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Oxygen uptake (peak VO2 [l/min])
Difference in oxygen uptake (peak VO2 \[l/min\]) of eccentric vs. concentric cycling exercise.
1 Day
Secondary Outcomes (15)
Respiratory exchange ratio (RER)
1 day
Breathing equivalent for carbon dioxide
1 day
Pulmonary end tidal carbon dioxide (PET CO2)
1 day
Arterial oxygen saturation (SpO2)
1 day
Borg Scale for dyspnea
1 day
- +10 more secondary outcomes
Study Arms (2)
Start with: Concentric (normal) cycling
SHAM COMPARATORPatients that are allocated to this arm will start with normal cycling
Start with: Eccentric cycling
EXPERIMENTALPatients that are allocated to this arm will start with eccentric cycling
Interventions
The exposure to eccentric exercise will be individualized-intensity stepwise incremental cycle exercise starting at 50 Watt with individually tailored increments every 5 minutes.
The exposure to concentric exercise will be individualized-intensity stepwise incremental cycle exercise starting at 50 Watt with individually tailored increments every 5 minutes.
Eligibility Criteria
You may qualify if:
- In a stable condition on the same disease specific medication \>4 weeks.
- Signed informed consent.
- Patients with chronic obstructive pulmonary (COPD) with a FEV1/FVC-ratio \> 0.7
You may not qualify if:
- Severe daytime hypoxemia (pO2 ≤7.3 kPa or \<55 mmHg).
- Other clinically significant concomitant disease states (e.g., renal, hepatic dysfunction, etc.).
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorder, dementia or confusional state of the subject, neurological or orthopedic problems with inability to ride a bicycle.
- Woman with known pregnancy (Women with known pregnancy will not be allowed into the study. It will however not be searched for early unknown pregnancy in woman of child-bearing potential, as cycling is not contraindicated in early unknown pregnancy stage and we thus do not plan routine pregnancy tests before study entrance in women of childbearing potential).
- Enrolment into another clinical trial with active treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Respiratory Clinic, University Hospital of Zurich
Zurich, Canton of Zurich, 8091, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 6, 2021
First Posted
January 11, 2022
Study Start
November 15, 2023
Primary Completion
May 31, 2024
Study Completion
May 31, 2024
Last Updated
January 23, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share